University of Connecticut:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:University of Connecticut - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9405
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
University of Connecticut (UCONN) is an educational service provider that offers graduation programs and other courses. The university offers undergraduate degree courses, graduate degree courses, professional degree programs, and research programs. It offers educational and training programs in business, dental medicine, health and natural resources, agricultural, engineering, fine arts, liberal arts and sciences, law, nursing, pharmacy and social work areas, among others. UCONN also conducts research on advanced materials characterization, biomedical devices, advanced materials and manufacturing, cyber security and others. The university operates through its labs, lecture halls and community facilities in Connecticut. UCONN is headquartered in Storrs, Connecticut, the US.

University of Connecticut – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
University of Connecticut, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
University of Connecticut, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
University of Connecticut, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
University of Connecticut, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
University of Connecticut, Medical Devices Deals, 2012 to YTD 2018 9
University of Connecticut, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
University of Connecticut, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
LambdaVision Raises US$0.11 Million In Venture Financing 11
Partnerships 12
Biohaven Pharma and University of Connecticut Enter into Research Agreement 12
CaroGen Enters into Agreement with University of Connecticut 13
Immunovaccine Extends Partnership with UConn Health 14
Jackson Labs and University of Connecticut Form Joint Venture 15
Licensing Agreements 16
Biohaven Pharma Enters into Licensing Agreement with University of Connecticut 16
HedgePath Pharma Enters into Option Agreement with University of Connecticut 17
University of Connecticut – Key Competitors 18
University of Connecticut – Key Employees 19
University of Connecticut – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
Government and Public Interest 21
Aug 10, 2018: Icahn Institute partners in $6.5 million NIH award to advance precision medicine and bioengineering capabilities 21
May 17, 2018: UConn Researchers Lead National Effort to Improve Drug Manufacturing 22
Apr 02, 2018: New Compound Helps Activate Cancer-Fighting T Cells 24
Mar 19, 2018: New Study Identifies Effective Treatments for Persistent Asthma 26
Oct 10, 2017: National MS Society Commits Nearly $14 Million to New Research to Stop Multiple Sclerosis, Restore Function and End MS Forever 28
Apr 24, 2017: Stem cells help researchers identify neuronal defects causing Angelman syndrome 29
Product News 31
Jan 15, 2018: Biodegradable Sensor Monitors Pressure in the Body then Disappears 31
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Tables
University of Connecticut, Pharmaceuticals & Healthcare, Key Facts 2
University of Connecticut, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
University of Connecticut, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
University of Connecticut, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
University of Connecticut, Deals By Therapy Area, 2012 to YTD 2018 8
University of Connecticut, Medical Devices Deals, 2012 to YTD 2018 9
University of Connecticut, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
LambdaVision Raises US$0.11 Million In Venture Financing 11
Biohaven Pharma and University of Connecticut Enter into Research Agreement 12
CaroGen Enters into Agreement with University of Connecticut 13
Immunovaccine Extends Partnership with UConn Health 14
Jackson Labs and University of Connecticut Form Joint Venture 15
Biohaven Pharma Enters into Licensing Agreement with University of Connecticut 16
HedgePath Pharma Enters into Option Agreement with University of Connecticut 17
University of Connecticut, Key Competitors 18
University of Connecticut, Key Employees 19
University of Connecticut, Subsidiaries 20

List of Figures
University of Connecticut, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
University of Connecticut, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
University of Connecticut, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
University of Connecticut, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
University of Connecticut, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
University of Connecticut, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
University of Connecticut, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
University of Connecticut, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
University of Connecticut, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[University of Connecticut:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Summit Pharmaceuticals International Corp:企業の戦略的SWOT分析
    Summit Pharmaceuticals International Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Atomo Diagnostics Pty Limited:企業の製品パイプライン分析2018
    Summary Atomo Diagnostics Pty Ltd (Atomo Diagnostics) is a medical device company that designs, develops, manufactures, and commercializes in-vitro diagnostic products. The company offers AtomoRapid HIV, a human immunodeficiency virus (HIV) rapid test kit; and AtomoRapid malaria, a kit to test malar …
  • Chuo Kagaku Co., Ltd.:企業の戦略・SWOT・財務情報
    Chuo Kagaku Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Chuo Kagaku Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Ezz Steel Company SAE:企業の戦略・SWOT・財務分析
    Ezz Steel Company SAE - Strategy, SWOT and Corporate Finance Report Summary Ezz Steel Company SAE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Nuance Communications, Inc. (NUAN)-医療機器分野:企業M&A・提携分析
    Summary Nuance Communications, Inc. (Nuance) is a provider of speech and imaging solutions. It offers solutions such as automated speech recognition, dialog management, capabilities for natural language understanding, optical character recognition (OCR), domain knowledge and implementation capabilit …
  • HP Inc.:企業の戦略・SWOT・財務情報
    HP Inc. - Strategy, SWOT and Corporate Finance Report Summary HP Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Cathay Pacific Airways Limited:戦略・SWOT・企業財務分析
    Cathay Pacific Airways Limited - Strategy, SWOT and Corporate Finance Report Summary Cathay Pacific Airways Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • CSI Compressco LP (CCLP):企業の財務・戦略的SWOT分析
    Summary CSI Compressco LP (CSI), a subsidiary of TETRA Technologies Inc, is an oilfield consulting company that offers compression services and equipment for natural gas and oil production, transportation, and storage. The company's products include real-time compressor monitoring systems, electrica …
  • Toshiba Corporation (6502)-エネルギー分野:企業M&A・提携分析
    Summary Toshiba Corporation (Toshiba) is an electronics, electrical equipment and information technology company. It offers digital consumer products such as LCD TV, Blue-ray disc servers, tablet and Note PC’s; electronic devices and components including solid-state drive NAND flash memory, hard dis …
  • Titan Company Ltd (TITAN):企業の財務・戦略的SWOT分析
    Summary Titan Company Ltd (Titan) is a retailing company. Its product portfolio includes eyewear, watches and accessories; jewelry; and fashion accessories. The company offers jewelry products comprising of pendant, chain, gold coin, earrings, finger ring and neckwear. Titan offers eyewear products …
  • Seafarms Group Limited (SFG):企業の財務・戦略的SWOT分析
    Seafarms Group Limited (SFG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Sun-Rype Products Ltd.:企業の戦略・SWOT・財務情報
    Sun-Rype Products Ltd. - Strategy, SWOT and Corporate Finance Report Summary Sun-Rype Products Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Acerus Pharmaceuticals Corp (ASP):製薬・医療:M&Aディール及び事業提携情報
    Summary Acerus Pharmaceuticals Corp (Acerus), formerly Trimel Pharmaceuticals Corporation develops, manufactures, markets and distributes novel innovative branded products. It focuses on providing men’s and women’s health. The company uses its proprietary drug delivery technology platforms, which in …
  • University of Strathclyde:製薬・医療:M&Aディール及び事業提携情報
    Summary University of Strathclyde (Strathclyde) is an educational service provider that offers education, learning technologies and facilities. The university offers a wide range of undergraduate and postgraduate programs, and distance learning programs through its faculties of engineering, science, …
  • SG Blocks, Inc. (SGBX):企業の財務・戦略的SWOT分析
    SG Blocks, Inc. (SGBX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Northern Power Systems Corp (NPS):企業の財務・戦略的SWOT分析
    Summary Northern Power Systems Corp (NPS), formerly Mira III Acquisition Corp is a renewable energy company that offers engineering solutions to energy sector. The company's products comprise wind turbines, power converters, microgrids, power technology products and others. It offers services such a …
  • Viterra Inc.:戦略・SWOT・企業財務分析
    Viterra Inc. - Strategy, SWOT and Corporate Finance Report Summary Viterra Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • BMO Capital and Income Investment Trust PLC:企業の戦略・SWOT・財務情報
    BMO Capital and Income Investment Trust PLC - Strategy, SWOT and Corporate Finance Report Summary BMO Capital and Income Investment Trust PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • Hewlett Packard Enterprise Company (HPE):企業の財務・戦略的SWOT分析
    Hewlett Packard Enterprise Company (HPE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Sanchez Energy Corp (SN):企業の財務・戦略的SWOT分析
    Summary Sanchez Energy Corp (Sanchez) is an independent exploration and production company that acquires and develops unconventional oil and natural gas resources. It operates in the horizontal development of resources from the Eagle Ford Shale in South Texas. The company also holds an undeveloped a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆